Skip to content


Cobra provides scale up and manufacturing of customers’ live biotherapeutic microbiota products, manufacturing to GMP standards for pre-clinical, clinical and commercial scale. Cobra is proud to be a part of the ELIMOX consortium; inspiring hope through medical advances.



  • Listeria monocytogenes (recombinant, attenuated)
  • Oxalobacter formigenes (wild type, anaerobic)
  • Salmonella tyhpi (recombinant, attenuated)
  • Salmonella typhimurium (recombinant, attenuated)
  • Serratia marcescens (wild type, heat-killed at end of process)
  • Streptococcus pyogenes (wild type, heat-killed at end of process)

Analytical Development & Qualification

  • Analytical method transfer, development, qualification & validation
  • Analytical methods include: Identity by microbiological characterisation of the strain, purity (monosepsis), strength by determination of viability, development of cell based potency assays

GMP Manufacturing

Cobra provides expert contract manufacturing of whole cell microbiota vaccines in compliance with GMP standards.

  • Master Cell Bank & Working Cell Bank production
  • Pre-clinical and clinical supply
  • Aerobic and anaerobic cell capability

Get In Touch

Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.